Our mission is to discover drugs for high unmet medical needs that will improve quality of life for patients with Rare Diseases.
We stand out by our ability to deliver high value products with relatively little cost in a short period of time, due to our model we reduce the risk of drug development.
SOM Biotech has a strong pipeline of products focused on CNS at preclinical and clinical stages.
NEWS & PRESS RELEASES
Undiagnosed Children’s Day 2018
Undiagnosed Children’s Day is a nationwide event in the UK that occurs on the last Friday […]
MedTeX: Acceleradora Tecnologies Mèdiques
MedTeX is a specialized acceleration program created by Parc Científic de Barcelona and Universitat de […]
6th Orphan Drugs & Rare Diseases Global Congress 2018 Europe
SOM Biotech was a proud sponsor of the “6th Orphan Drugs & Rare Diseases Global Congress […]
Bio International Seminar II: European Insights in Life Sciences Innovation
SOM Biotech CEO, Dr. Raúl Insa, graced the 2nd Bio International Seminar as one of the keynote […]
SOM Biotech wins Premio Hito Tecnológico
El Suplemento, the organizer of Premios Tecnológia Siglo XXI 2018, has awarded SOM Biotech in the Hito Tecnológico (Technological Milestone) […]
SOM Biotech joins in raising awareness of rare diseases
To show its support for raising public awareness of rare diseases, SOM Biotech joins the Rare […]
World Rare Disease Day 2018
Since 2008, World Rare Disease Day is celebrated on the last day of February each […]
SOM Biotech at Biotech & Money Congress 2018
SOM Biotech CEO, Dr. Raúl Insa, will attend the Biotech & Money Congress in London […]
Duchenne Parent Project España y SOM Biotech renuevan su acuerdo de colaboración
Tras los resultados obtenidos durante el primer año de colaboración, la Asociación Duchenne Parent Project […]
2017: A landmark year for SOM Biotech
As 2017 comes to a close, it is a great time of year for business […]